Zevra Therapeutics, Inc. Amortization of Debt Issuance Costs and Discounts
Zevra Therapeutics, Inc. (ZVRA) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2023-03-07
- Zevra Therapeutics, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-12-31 was $0.00.
- Zevra Therapeutics, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-09-30 was $0.00.
- Zevra Therapeutics, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-06-30 was $0.00.
- Zevra Therapeutics, Inc. amortization of debt issuance costs and discounts for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Zevra Therapeutics, Inc. amortization of debt issuance costs and discounts for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Zevra Therapeutics, Inc. amortization of debt issuance costs and discounts for fiscal 2021 was $150.00K, a 93.49% decline from fiscal 2020.
- Zevra Therapeutics, Inc. amortization of debt issuance costs and discounts for fiscal 2020 was $2.31M, a 39.19% increase from fiscal 2019.
- Zevra Therapeutics, Inc. amortization of debt issuance costs and discounts for fiscal 2019 was $1.66M, a 2.35% increase from fiscal 2018.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $0.00 derived: sum of 2 quarters · filed 2023-03-07 | $0.00 derived: sum of 3 quarters · filed 2023-03-07 | $0.00 10-K · filed 2023-03-07 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2023-03-07 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $0.00 derived: sum of 3 quarters · filed 2023-03-07 | $0.00 derived: sum of 4 quarters · filed 2023-03-07 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-07 | $0.00 derived: sum of 3 quarters · filed 2023-03-07 | $0.00 derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $0.00 derived: sum of 2 quarters · filed 2023-03-07 | $0.00 derived: sum of 3 quarters · filed 2023-03-07 | $150.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $150.00K 10-Q · filed 2022-11-10 | $732.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | $150.00K 10-Q · filed 2022-08-12 | $732.00K derived: sum of 3 quarters · filed 2022-08-12 | $1.31M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $150.00K 10-Q · filed 2022-05-12 | $732.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.31M derived: sum of 3 quarters · filed 2022-05-12 | $1.88M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $582.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.16M derived: sum of 2 quarters · filed 2022-03-31 | $1.73M derived: sum of 3 quarters · filed 2022-03-31 | $2.31M 10-K · filed 2022-03-31 |
| 2020-09-30 | $578.00K 10-Q · filed 2021-11-10 | $1.15M derived: sum of 2 quarters · filed 2021-11-10 | $1.72M 10-Q · filed 2021-11-10 | $2.40M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $574.00K 10-Q · filed 2021-08-13 | $1.15M 10-Q · filed 2021-08-13 | $1.82M derived: sum of 3 quarters · filed 2021-08-13 | $2.19M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $571.00K 10-Q · filed 2021-05-14 | $1.25M derived: sum of 2 quarters · filed 2021-05-14 | $1.62M derived: sum of 3 quarters · filed 2021-05-14 | $1.92M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $675.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.05M derived: sum of 2 quarters · filed 2021-03-12 | $1.35M derived: sum of 3 quarters · filed 2021-03-12 | $1.66M 10-K · filed 2021-03-12 |
| 2019-09-30 | $371.00K 10-Q · filed 2020-10-30 | $676.00K derived: sum of 2 quarters · filed 2020-10-30 | $981.00K 10-Q · filed 2020-10-30 | $1.49M derived: sum of 4 quarters · filed 2020-10-30 |
| 2019-06-30 | $305.00K 10-Q · filed 2020-08-12 | $610.00K 10-Q · filed 2020-08-12 | $1.12M derived: sum of 3 quarters · filed 2020-08-12 | $1.45M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $305.00K 10-Q · filed 2020-05-13 | $817.00K derived: sum of 2 quarters · filed 2020-05-13 | $1.14M derived: sum of 3 quarters · filed 2020-05-13 | $1.53M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $838.00K derived: sum of 2 quarters · filed 2020-02-28 | $1.23M derived: sum of 3 quarters · filed 2020-02-28 | $1.62M 10-K · filed 2020-02-28 |
| 2018-09-30 | $326.00K 10-Q · filed 2019-11-14 | $716.00K derived: sum of 2 quarters · filed 2019-11-14 | $1.11M 10-Q · filed 2019-11-14 | $1.50M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $390.00K 10-Q · filed 2019-08-13 | $780.00K 10-Q · filed 2019-08-13 | $1.17M derived: sum of 3 quarters · filed 2019-08-13 | $1.56M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $390.00K 10-Q · filed 2019-05-14 | $780.00K derived: sum of 2 quarters · filed 2019-05-14 | $1.17M derived: sum of 3 quarters · filed 2019-05-14 | $1.56M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $390.00K 10-K · filed 2018-03-30 | $781.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.17M derived: sum of 3 quarters · filed 2018-11-09 | $1.56M 10-K · filed 2019-03-01 |
| 2017-09-30 | $391.00K 10-Q · filed 2018-11-09 | $781.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.17M 10-Q · filed 2018-11-09 | $1.56M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | $390.00K 10-Q · filed 2018-08-10 | $780.00K 10-Q · filed 2018-08-10 | $1.17M derived: sum of 3 quarters · filed 2018-08-10 | $1.56M derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $390.00K 10-Q · filed 2018-05-11 | $781.00K derived: sum of 2 quarters · filed 2018-05-11 | $1.17M derived: sum of 3 quarters · filed 2018-05-11 | $1.56M derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $391.00K 10-K · filed 2018-03-30 | $781.00K derived: sum of 2 quarters · filed 2018-03-30 | $1.17M derived: sum of 3 quarters · filed 2018-03-30 | $1.62M 10-K · filed 2018-03-30 |
| 2016-09-30 | $390.00K 10-K · filed 2018-03-30 | $783.00K derived: sum of 2 quarters · filed 2018-03-30 | $1.23M 10-Q · filed 2017-11-09 | $1.70M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-06-30 | $393.00K 10-K · filed 2018-03-30 | $835.00K 10-Q · filed 2017-08-10 | $1.31M derived: sum of 3 quarters · filed 2018-03-30 | $1.79M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-03-31 | $442.00K 10-K · filed 2018-03-30 | $917.00K derived: sum of 2 quarters · filed 2018-03-30 | $1.40M derived: sum of 3 quarters · filed 2018-03-30 | $1.87M derived: sum of 4 quarters · filed 2018-03-30 |
| 2015-12-31 | $475.00K 10-K · filed 2017-03-10 | $954.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.43M derived: sum of 3 quarters · filed 2017-03-10 | $1.91M 10-K · filed 2018-03-30 |
| 2015-09-30 | $479.00K 10-K · filed 2017-03-10 | $956.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.43M 10-Q · filed 2016-11-10 | $1.91M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $477.00K 10-K · filed 2017-03-10 | $954.00K 10-Q · filed 2016-08-11 | $1.43M derived: sum of 3 quarters · filed 2017-03-10 | $1.91M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $477.00K 10-K · filed 2017-03-10 | $955.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.43M derived: sum of 3 quarters · filed 2017-03-10 | $1.59M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | $478.00K 10-K · filed 2016-03-16 | $955.00K derived: sum of 2 quarters · filed 2016-03-16 | $1.11M derived: sum of 3 quarters · filed 2016-03-16 | $1.11M 10-K · filed 2017-03-10 |
| 2014-09-30 | $477.00K 10-K · filed 2016-03-16 | $636.00K derived: sum of 2 quarters · filed 2016-03-16 | $636.00K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $159.00K 10-K · filed 2016-03-16 | $159.00K 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | $0.00 10-K · filed 2016-03-16 | |||
| 2013-12-31 | $1.56M 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |